Conclusion Our work demonstrates that TRAF3 mutations and deletions are highly enriched in CLL patients with del-3’IGH, resulting in the biallelic inactivation of this gene. The presence of this double-hit on TRAF3 worsen the prognosis of CLL patients, being and independent prognostic factor with similar impact on TFT than the biallelic loss of TP53 .
over 2 years ago
TP53 (Tumor protein P53) • NOTCH1 (Notch 1) • CD19 (CD19 Molecule) • IGH (Immunoglobulin Heavy Locus)